Findings from a new study has shown that early response to ixekizumab and ustekinumab is associated with maintaining stable long-term skin clearance in patients with moderate-to-severe psoriasis.
Self-help interventions help reduce shame and improve QOL in psoriasis patients, study shows
According to a new study, some psoriasis patients may experience a reduction in shame and improvement in quality of life (QOL) after exposure to self-help interventions.
Psoriasis patients experience vaccine hesitancy and treatment disruptions during pandemic
A new study evaluates vaccine hesitancy and medication changes in psoriasis patients during the Covid-19 pandemic.
New study shows Tapinarof cream reduces severity of plaque psoriasis
Tapinarof 1% cream was superior to vehicle control in reducing the severity of plaque psoriasis over a 12 week period, according to a new study.
New study links key protein to inflammation in psoriasis patients
Researchers have linked a key protein called TWEAK to inflammation in psoriasis patients.
Risankizumab worsened symptoms in patients with severe asthma, new study finds
A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.
Researchers gather real world treatment data on psoriatic arthritis patients
Researchers have surveyed 137 respondents from a psoriatic arthritis (PsA) registry for phenotypic features and characteristics, initial and current therapies, and medication preference.
Hepatitis C linked to increased risk for chronic inflammatory skin diseases, study shows
According to a new study, hepatitis C virus (HCV) infection is linked to an increased risk for chronic inflammatory skin diseases (CISDs). The study showed a decreased risk for CISD when treated with interferon-based antiviral therapy.
Study suggests biologics are safe in patients with inflammatory skin disease during pandemic
A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.
Researchers target skin protein that may be linked to severity of psoriasis
New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.
HealthMinute.TV 